20% Sulfadiazine+4% Ọgwụ mgbochi Trimethoprim
.png)
.png)
.png)
.png)
Ihe na-arụ ọrụ
Sulfadiazine 20.00% w/v.
Trimethoprim 4.00% w/v
Pharmacological omume
Sulfadiazine bụ ọgwụ sulfa nke na-arụ ọrụ nke ọma maka usoro eji eme ihe yana ọ bụ ihe na-akpata nje bacteria dị iche iche.Usoro ya na-eme bụ n'ihi na ọ dị ka p-aminobenzoic acid (PABA) ma nwee ike ịsọ mpi na PABA iji mee ihe na dihydrofolate synthase na nje bacteria, si otú ahụ na-egbochi PABA ka ọ bụrụ ihe eji eme ihe iji mepụta tetrahydrofolate nke nje bacteria chọrọ, si otú ahụ. na-egbochi njikọ nke protein nje na-arụ mmetụta antibacterial.
Ntinye aka
Ngwọta injectable a ka egosiri na ọgwụgwọ nke ọrịa sistemu nke sitere na ma ọ bụ jikọtara ya na ntule nwere mmetụta nke Trimethoprim: Sulfadiazine ngwakọta.Ụdị ọrụ dị iche iche na-agụnye ma gram-positive na Gram-negative organisms gụnyere: Actinobacilli, Actinomycae, Bordetella spp, Brucella Corynebacteria, Escherichia coli, Haemophilus spp.Klebsiella spp, Pasteurella spp, Pneumococci.Proteus, Salmonella spp.Staphylococci, streptococci, Vibrio.
Usoro onunu ogwu na nchịkwa
Site na ntụtụ subcutaneous naanị.
Ehi: Ọnụego ọgwụ akwadoro bụ 15 mg nke ihe na-arụ ọrụ kwa kilogram nke ịdị arọ ahụ (1 ml kwa 16kg arọ ahụ) site na ntụtụ intramuscular ma ọ bụ nwayọ.
Ịnyịnya: Ọnụego dose a tụrụ aro bụ 15 mg nke ihe na-arụ ọrụ kwa kilogram nke ịdị arọ ahụ (1 ml kwa kilogram 16 n'arọ), site na ịgba ọgwụ mgbochi ngwa ngwa.
Nkịta na nwamba: Ọnụego ọgwụ akwadoro bụ 30mg nke ihe na-arụ ọrụ kwa kilogram arọ (1 ml kwa kilogram 8 n'arọ).
Contraindications
E kwesịghị inye ọgwụ ntụtụ ahụ site n'ụzọ ndị ọzọ karịa nke akwadoro.
A gaghị enye ya intraperitoneal, intra- arterially ma ọ bụ intrathecally.
Edola anụmanụ ndị nwere mmetụta sulphonamide amaara, mmebi imeju parenchymal siri ike ma ọ bụ dyscrasias ọbara.
Ịdọ aka ná ntị pụrụ iche
1 Maka nchịkwa intravenous, ngwaahịa ahụ kwesịrị ikpo ọkụ ka ọ dị ọkụ ma gbanye ya nwayọ ruo ogologo oge dịka ọ bara uru.
2 N'ihe ịrịba ama mbụ nke enweghị ndidi, a ga-akwụsị ịgba ọgwụ ahụ ma malite ọgwụgwọ ujo.
Mmiri ọṅụṅụ zuru oke kwesịrị ịdị n'oge mmetụta ọgwụgwọ nke ngwaahịa ahụ.
Oge mwepụ
Ehi : Anụ - 12 ụbọchị
Mmiri ara ehi - 4 ụbọchị.
Nchekwa
Chebe pụọ na ìhè anyanwụ kpọmkwem ma chekwaa n'okpuru 30 ℃.
Hebei Veyong Pharmaceutical Co., Ltd, e guzobere na 2002, emi odude ke Shijiazhuang City, Hebei Province, China, na-esote Isi Obodo Beijing.Ọ bụ nnukwu ụlọ ọrụ ọgwụ anụmanụ enwetara ikike nke GMP, yana R&D, mmepụta na ire nke API ọgwụgwọ anụmanụ, nkwadebe, nri agbakwunyere na mgbakwunye nri.Dị ka Provincial Technical Center, Veyong eguzobela usoro R&D ọhụrụ maka ọgwụ anụmanụ ọhụrụ, ma bụrụ ụlọ ọrụ mmepụta ihe ọhụrụ na teknụzụ nke mba ama ama, enwere ndị ọkachamara teknụzụ 65.Veyong nwere abụọ mmepụta bases: Shijiazhuang na Ordos, nke Shijiazhuang isi na-ekpuchi ebe 78,706 m2, na 13 API ngwaahịa gụnyere Ivermectin, Eprinomectin, Tiamulin Fumarate, Oxytetracycline hydrochloride ects, na 11 nkwadebe mmepụta akara gụnyere injection, oral ngwọta, ntụ ntụ ngwọta. , premix, bolus, pesticides na disinfectant, wdg.Veyong na-enye API, ihe karịrị 100 nkwado akara aha, yana ọrụ OEM & ODM.
Veyong na-etinye aka na njikwa nke sistemụ EHS (Environment, Health & Safety), ma nweta asambodo ISO14001 na OHSAS18001.Edepụtara Veyong n'ime ụlọ ọrụ mmepụta ihe na-emepụta atụmatụ dị na Hebei Province ma nwee ike hụ na ngwaahịa na-aga n'ihu.
Veyong guzobere usoro njikwa mma zuru oke, nweta asambodo ISO9001, asambodo China GMP, asambodo Australia APVMA GMP, asambodo Ethiopia GMP, asambodo Ivermectin CEP, wee gafere nyocha US FDA.Veyong nwere ọkachamara otu ndebanye aha, ahịa na ọrụ teknụzụ, ụlọ ọrụ anyị enwetala ntụkwasị obi na nkwado site n'aka ọtụtụ ndị ahịa site n'ịdị mma ngwaahịa dị mma, ọrụ tupu ire ere na mgbe ire ere, ọrụ siri ike na sayensị.Veyong emewo ogologo okwu imekọ ihe ọnụ na ọtụtụ mba ụwa maara na-emepụta ọgwụ ụlọ ọrụ na ngwaahịa exported na Europe, South America, Middle East, Africa, Asia, wdg karịa 60 mba na mpaghara.
